Clinical Trials Logo

Filter by:
NCT ID: NCT04087928 Completed - Stroke Clinical Trials

Focal Muscular Vibration to Treat Upper Limb Spasticity in Stroke

Start date: September 16, 2019
Phase: N/A
Study type: Interventional

Spasticity following stroke is one of the most debilitating conditions and has a negative influence on the autonomy and quality of life, and greatly worsens the patient's degree of disability. Focal muscular vibration (FMV) is a non-invasive technique to treat spasticity. Has been showed the positive effects of FMV on spasticity in stroke subjects. FMV has been investigated on the antagonist muscle, as well as directly on the spastic muscle, showing in both cases a significant reduction in spasticity. However, isn't unclear which is the most effective in the treatment of spasticity. The objective of the study is to evaluate the efficacy of FMV of the muscles of the upper limb in subjects with subacute stroke, comparing the effects obtained by treating the spastic muscles directly versus to those obtained by treating the respective antagonist muscles.

NCT ID: NCT04087733 Completed - Ocular Infections Clinical Trials

Effectiveness of Liposomial Ozonized-Oil for Cataract Surgery

Start date: October 1, 2019
Phase: Phase 4
Study type: Interventional

Evaluation of the antimicrobial efficacy of a liposomal ozone-based solution (OZODROP®) , vs placebo in 200 patients undergoing cataract surgery by phacoemulsification . The clinical trial will last 3 days of treatment per patient. The conjunctival swab will be taken for each of the two eyes (in treatment and control) at T0 (before starting the treatment - 3 days before the cataract surgery) and at T3 (after 3 days of treatment - immediately before the cataract surgery). The last OZODROP instillation will take place 10 minutes before taking the sample.

NCT ID: NCT04087681 Completed - E.Coli Infections Clinical Trials

Study to Collect Information About Invasive Disease Caused by Extraintestinal Pathogenic Escherichia Coli (EXPECT-1)

EXPECT-1
Start date: September 28, 2019
Phase:
Study type: Observational

The purpose of this study is to collect information from study participants who develop an invasive disease caused by Extraintestinal pathogenic E. coli (ExPEC) during a period of 12 months. This information will be used to support the development of a new vaccine to prevent ExPEC infections.

NCT ID: NCT04087200 Recruiting - Clinical trials for Acute Coronary Syndrome

Protective Effect of Early High Dose stATins On Cardiovascular and Renal Events in Acute Coronary Syndrome

PRATO-ACS
Start date: December 1, 2016
Phase:
Study type: Observational [Patient Registry]

Registration of all ACS patients (STEMI and NSTEMI) admitted to the cardiology ward and scheduled for early invasive strategy. The aim is to evaluate the protective effects of early (on admission) high-dose high-potency statin therapy on early and mid-term cardiac and renal events in this subset of patients.

NCT ID: NCT04087083 Recruiting - Stroke Clinical Trials

Innovative Models in the Rehabilitation of the Elderly With Stroke Through Technological Innovation

Start date: February 15, 2021
Phase: N/A
Study type: Interventional

The final goal of the present study is to propose a new approach and an innovative therapeutic plan in the post-stroke rehabilitation of elderly patients, focused on the use of robotic device, in order to obtain the beneficial effects of this treatment.

NCT ID: NCT04087031 Recruiting - Parkinson Disease Clinical Trials

Innovative Models in the Rehabilitation of the Elderly With Parkinson's Disease Through Technological Innovation

Start date: December 3, 2019
Phase: N/A
Study type: Interventional

The final goal of the present study is to propose a new approach in the Parkinson's Disease rehabilitation, focused on the use of robotic devices and to check the results not only at the end of the treatment but also in the long term, foreseeing 3 follow-up.

NCT ID: NCT04086550 Recruiting - Clinical trials for Cerebrospinal Fluid Leak

Evaluate the Safety and Efficacy of Dura Sealant Patch in Reducing CSF Leakage Following Elective Cranial Surgery

ENCASE-II
Start date: May 20, 2021
Phase: N/A
Study type: Interventional

The objective of the study is to clinically assess the safety and effectiveness of LIQOSEAL® as a means of reducing intra- as well as post-operative CSF leakage in patients undergoing elective cranial intradural surgery with a dural closure procedure to show noninferiority compared to a control group.

NCT ID: NCT04086498 Completed - Overweight Clinical Trials

Effects of a Ketogenic Diet on Psychological Outcomes

Start date: April 1, 2015
Phase: N/A
Study type: Interventional

The aim of the study is to investigate how glycemia and ketonemia variations during three different diet protocols: a ketogenic diet without any restriction on calories intake (KD), a calorie-restricted ketogenic-mediterranean diet (KEMEPHY) and a calorie-restricted mediterranean diet (MD) affect appetite, executive functions and mood in overweight young women.

NCT ID: NCT04086264 Active, not recruiting - Clinical trials for Acute Myeloid Leukemia

IMGN632 as Monotherapy or With Venetoclax and/or Azacitidine for Participants With CD123-Positive Acute Myeloid Leukemia

Start date: November 6, 2019
Phase: Phase 1/Phase 2
Study type: Interventional

This is an open-label, multicenter, Phase 1b/2 study to determine the safety and tolerability of IMGN632 and assess the antileukemia activity of IMGN632 when administered in combination with azacitidine and/or venetoclax in participants with relapsed and frontline CD123-positive AML.

NCT ID: NCT04085731 Recruiting - Clinical trials for Persistent Atrial Fibrillation

Driver-guided Ablation of Persistent Atrial Fibrillatiom

Start date: September 21, 2019
Phase:
Study type: Observational [Patient Registry]

This is a prospective, single-center, study. A targeted number of 181patients with persistent AF will be included according to pre-defined criteria. The ablation procedure consists on the identification of the arrhythmic substrate using a novel integrated mapping technique. We hypothesize that such approach may potentially lead to a mechanisms-targeted ablation strategy of persistent AF.